XML 56 R6.htm IDEA: XBRL DOCUMENT v3.24.3Close
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 1,719.1 $ 1,362.1
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation, amortization and impairment of property, equipment and software 188.4 181.6
Amortization and impairment of acquisition-related assets and retention arrangements 196.5 165.6
Fair value remeasurement of contingent consideration liability (13.4) (72.8)
Stock-based compensation expense 162.2 169.7
Net gains recognized on investments (332.1) (300.4)
Net redemptions in sponsored investment products used to economically hedge supplemental savings plan liability 29.8 101.3
Net change in securities held by consolidated sponsored investment products (517.9) (779.9)
Other changes in assets and liabilities 534.9 549.3
Net cash provided by operating activities 1,967.5 1,376.5 Close
Cash flows from investing activities    
Purchases of sponsored investment products (89.4) (35.8)
Dispositions of sponsored investment products 303.1 370.7
Net cash of sponsored investment products on deconsolidation (15.7) (35.6)
Additions to property, equipment and software (310.4) (226.0)
Other investing activity (42.6) (35.2)
Net cash (used in) provided by investing activities (155.0) 38.1 Close
Cash flows from financing activities    
Repurchases of common stock (269.1) (141.2)
Common share issuances under stock-based compensation plans 28.1 25.5
Dividends paid to common stockholders of T. Rowe Price Group, Inc. (851.0) (842.0)
Net contributions (distributions) to non-controlling interests in consolidated entities 2.6 (3.2)
Net subscriptions from redeemable non-controlling interest holders 361.2 343.7
Net cash used in financing activities (728.2) (617.2) Close
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products 0.5 (1.8) Close
Net change in cash and cash equivalents during period 1,084.8 795.6 Close
Cash and cash equivalents at beginning of period, including $77.2 million at December 31, 2023, and $119.1 million at December 31, 2022, held by consolidated sponsored investment products 2,143.8 1,874.7
Cash and cash equivalents at end of period, including $55.1 million at September 30, 2024, and $91.6 million at September 30, 2023, held by consolidated sponsored investment products $ 3,228.6 $ 2,670.3